Barclays’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.04M | Sell |
56,300
-515,100
| -90% | -$39.7M | ﹤0.01% | 1946 |
|
|
2025
Q4 | $45.3M | Sell |
571,400
-384,000
| -40% | -$30.3M | 0.01% | 824 |
|
|
2025
Q3 | $72M | Buy |
955,400
+169,300
| +22% | +$11.6M | 0.02% | 612 |
|
|
2025
Q2 | $54.2M | Buy |
786,100
+700,300
| +816% | +$45.9M | 0.01% | 679 |
|
|
2025
Q1 | $5.81M | Sell |
85,800
-548,400
| -86% | -$32.8M | ﹤0.01% | 1793 |
|
|
2024
Q4 | $28.5M | Buy |
634,200
+153,700
| +32% | +$8.62M | 0.01% | 923 |
|
|
2024
Q3 | $30.2M | Sell |
480,500
-986,600
| -67% | -$57.6M | 0.01% | 868 |
|
|
2024
Q2 | $86.6M | Buy |
1,467,100
+1,284,552
| +704% | +$80.4M | 0.03% | 438 |
|
|
2024
Q1 | $14.6M | Sell |
182,548
-85,052
| -32% | -$6.5M | 0.01% | 1160 |
|
|
2023
Q4 | $21.1M | Sell |
267,600
-374,200
| -58% | -$26.6M | 0.01% | 1027 |
|
|
2023
Q3 | $44.8M | Buy |
+641,800
| New | +$45.5M | 0.03% | 516 |
|
|
2023
Q1 | – | Sell |
-57,400
| Closed | -$5.35M | – | 5135 |
|
|
2022
Q4 | $5.35M | Buy |
57,400
+30,000
| +109% | +$2.89M | ﹤0.01% | 1574 |
|
|
2022
Q3 | $2.61M | Hold |
27,400
| – | – | ﹤0.01% | 1559 |
|
|
2022
Q2 | $2.54M | Hold |
27,400
| – | – | ﹤0.01% | 1685 |
|
|
2022
Q1 | $2.77M | Sell |
27,400
-2,600
| -9% | -$273K | ﹤0.01% | 1617 |
|
|
2021
Q4 | $3.1M | Buy |
+30,000
| New | +$2.77M | ﹤0.01% | 2074 |
|
|
2021
Q3 | – | Sell |
-100,000
| Closed | -$8.34M | – | 4777 |
|
|
2021
Q2 | $8.34M | Buy |
+100,000
| New | +$8.19M | ﹤0.01% | 1287 |
|
|
2021
Q1 | – | Sell |
-823,635
| Closed | -$56.3M | – | 4778 |
|
|
2020
Q4 | $56.3M | Buy |
823,635
+240,000
| +41% | +$15.6M | 0.03% | 426 |
|
|
2020
Q3 | $34.1M | Sell |
583,635
-5,300
| -0.9% | -$330K | 0.02% | 520 |
|
|
2020
Q2 | $38.3M | Buy |
588,935
+14,600
| +3% | +$919K | 0.03% | 399 |
|
|
2020
Q1 | $34.1M | Sell |
574,335
-671,561
| -54% | -$44.8M | 0.03% | 432 |
|
|
2019
Q4 | $92.6M | Buy |
1,245,896
+469,477
| +60% | +$33M | 0.05% | 286 |
|
|
2019
Q3 | $49M | Sell |
776,419
-3,773,655
| -83% | -$224M | 0.03% | 473 |
|
|
2019
Q2 | $248M | Buy |
4,550,074
+459,427
| +11% | +$24.7M | 0.15% | 102 |
|
|
2019
Q1 | $221M | Buy |
4,090,647
+1,793,198
| +78% | +$111M | 0.15% | 97 |
|
|
2018
Q4 | $151M | Buy |
2,297,449
+1,845,149
| +408% | +$138M | 0.12% | 125 |
|
|
2018
Q3 | $35.6M | Buy |
452,300
+212,600
| +89% | +$15.2M | 0.02% | 567 |
|
|
2018
Q2 | $15.4M | Buy |
239,700
+179,600
| +299% | +$11.8M | 0.01% | 938 |
|
|
2018
Q1 | $3.74M | Sell |
60,100
-19,400
| -24% | -$1.39M | ﹤0.01% | 1857 |
|
|
2017
Q4 | $5.76M | Sell |
79,500
-52,400
| -40% | -$3.81M | ﹤0.01% | 1563 |
|
|
2017
Q3 | $10.7M | Sell |
131,900
-268,500
| -67% | -$21.2M | 0.01% | 1011 |
|
|
2017
Q2 | $32.2M | Buy |
400,400
+41,400
| +12% | +$3.27M | 0.03% | 413 |
|
|
2017
Q1 | $28.2M | Buy |
359,000
+50,000
| +16% | +$3.99M | 0.03% | 428 |
|
|
2016
Q4 | $24.4M | Buy |
309,000
+144,600
| +88% | +$11.7M | 0.03% | 513 |
|
|
2016
Q3 | $14.6M | Sell |
164,400
-18,500
| -10% | -$1.75M | 0.02% | 674 |
|
|
2016
Q2 | $17.5M | Buy |
182,900
+2,500
| +1% | +$249K | 0.02% | 574 |
|
|
2016
Q1 | $18.6M | Sell |
180,400
-4,200
| -2% | -$408K | 0.03% | 500 |
|
|
2015
Q4 | $17.9M | Buy |
184,600
+76,500
| +71% | +$7.49M | 0.02% | 620 |
|
|
2015
Q3 | $10.4M | Sell |
108,100
-19,600
| -15% | -$2.06M | 0.01% | 910 |
|
|
2015
Q2 | $13.3M | Sell |
127,700
-8,900
| -7% | -$909K | 0.01% | 860 |
|
|
2015
Q1 | $14.1M | Sell |
136,600
-192,700
| -59% | -$19.5M | 0.02% | 884 |
|
|
2014
Q4 | $31.6M | Buy |
329,300
+194,500
| +144% | +$17.1M | 0.03% | 532 |
|
|
2014
Q3 | $10.6M | Buy |
134,800
+2,400
| +2% | +$189K | 0.01% | 1131 |
|
|
2014
Q2 | $9.93M | Buy |
132,400
+24,700
| +23% | +$1.87M | 0.01% | 1163 |
|
|
2014
Q1 | $7.97M | Sell |
107,700
-159,500
| -60% | -$11.3M | 0.01% | 1323 |
|
|
2013
Q4 | $19M | Buy |
267,200
+20,800
| +8% | +$1.34M | 0.02% | 793 |
|
|
2013
Q3 | $13.8M | Buy |
246,400
+168,100
| +215% | +$10M | 0.02% | 910 |
|
|
2013
Q2 | $4.48M | Buy |
+78,300
| New | +$4.54M | 0.01% | 1714 |
|
Other funds holding CVS
VCM
VPM
Barclays's CVS Position: Q1 2026 in Review
Barclays increased its CVS Health (CVS) stake by 1.1% in Q1 2026, buying an estimated $2.39M and bringing the position to 2,761,283 shares worth $198M. The position accounts for 0.05% of the portfolio, ranked #295.
Barclays first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $526M in Q1 2017. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Barclays held 2,761,283 shares of CVS Health worth $198M as of Q1 2026.
- Barclays bought 31,056 CVS Health shares in Q1 2026, an estimated $2.39M.
- CVS Health made up 0.05% of Barclays's portfolio in Q1 2026, its #295 holding.
- Barclays first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Barclays's CVS Health position peaked at $526M in Q1 2017.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.